You have to understand that Q1 is historically the strongest quarter for the supplement industry. I figured they would do better than Q4 but didn't think they would beat last year's Q1.
They have been trying to grow revenue by every means necessary except if it meant forging some executive compensation. Then growth as well as financial health and investor sentiment takes a back seat. That shows me where their real interests lie.
Anyway, good on picking some up in the low 3's. Now scalp that profit.
News 
Market Data 
Discover 
